Sharekhan

Sanofi Consumer Healthcare India Ltd

Fri 25/04/2025,9:34:52 NSE: SANOFICONR

₹ 4943.00 5.30 (0.11%)
BUY NOW Buy Sanofi Consumer Healthcare India Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Sanofi Consumer Healthcare India Ltd

Fri 25/04/2025,9:42:0

Sanofi Consumer Healthcare India Ltd

Fri 25/04/2025,9:34:52 | NSE : SANOFICONR

₹ 4943.005.30 (0.11%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 4954.80

Previous Close

₹ 4937.70

Volume

752

Mkt Cap ( Rs. Cr)

₹11384.04

High

₹ 4955.10

Low

₹ 4937.70

52 Week High

₹ 5375.00

52 Week Low

₹ 4211.55

Book Value Per Share

₹ 99.71

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Sanofi Consumer Healthcare India Ltd

Your Vote -

Buy

88.89%

Hold

0.00%

Sell

11.11%

88.89%

9 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

65%

Sell Order Quantity

35%

Bid Price

Qty

4945.30

3

4945.00

3

4944.00

1

4944.00

1

4942.00

1

Bid Total

6105

Bid Price

Qty

4948.00

5

4949.00

12

4950.00

2

4950.00

99

4950.00

429

Bid Total

3341

Option Chain

Analyzes market sentiment, predicts Sanofi Consumer Healthcare India Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sanofi Consumer Heal - Updates on Open Offer

    24 Apr 2025, 5:46PM Citigroup Global Markets India Pvt. Ltd. (\Manager to the Offer\) has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulatio

  • Sanofi Consumer Heal - Corrigendum

    23 Apr 2025, 7:26PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Corrigendum to the Annual Report for Financial Year 2024

  • Sanofi Consumer Heal - Corrigendum To The Annual Report For Financial Year 2024

    23 Apr 2025, 7:25PM Corrigendum to the Annual Report for Financial Year 2024

  • Sanofi Consumer Heal - Reg. 34 (1) Annual Report.

    23 Apr 2025, 5:57PM Corrigendum to the Annual Report for Financial Year 2024 due to inadvertent typographical errors in the disclosed figures on page no.53 under the sect

  • Sanofi Consumer Heal has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    21 Apr 2025, 8:00PM As of March 2025, 60.40% is owned by Foreign Promoters and 39.60% by Public. <p align=justify> Institutional holds 30.00% (Insurance Companies 9.78%)

  • Sanofi Consumer Heal - Updates

    16 Apr 2025, 10:56AM Citigroup Global Markets India Private Limited has Submitted to the Exchange a copy of Letter of Offer.

  • Sanofi Consumer Heal - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    15 Apr 2025, 5:08PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Sanofi Consumer Heal - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    15 Apr 2025, 5:10PM Certificate under Reg 74(5) of the SEBI (Depositories and Participants) regulations, 2018 for quarter ended March 31, 2025.

  • Sanofi Consumer Heal - Copy of Newspaper Publication

    13 Apr 2025, 6:48PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of Notice of Annual General Meeting and E-votin

  • Sanofi Consumer Heal - Notice Of Shareholders Meetings-XBRL

    13 Apr 2025, 12:46PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 05-Ma

  • Sanofi Consumer Heal - Shareholders meeting

    12 Apr 2025, 7:29PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on May 05, 2025

  • Sanofi Consumer Heal - Business Responsibility and Sustainability Reporting (BRSR)

    12 Apr 2025, 7:24PM Business Responsibility and Sustainibility Report (BRSR) for the Year 2024

  • Sanofi Consumer Heal has declared 550% Final dividend for the financial year December 2024

    12 Apr 2025, 7:20PM Sanofi Consumer Healthcare India Ltd. on Thursday, 20 February 2025, has announced Final dividend of 550 percent on Equity Share, to its shareholders

  • Sanofi Consumer Heal - Shareholder Meeting - AGM On May 5, 2025

    12 Apr 2025, 7:20PM Shareholder Meeting - AGM on May 5, 2025

  • Sanofi Consumer Heal - Reg. 34 (1) Annual Report.

    12 Apr 2025, 7:15PM Please find enclosed Annual Report for Financial Year 2024.

  • Sanofi Consumer Heal - Newspaper Publication Of Recommendations By The Committee Of Independent Directors Pursuant To Regulat

    11 Apr 2025, 3:46PM Newspaper Publication of Recommendations by the Committee of Independent Directors pursuant to Regulation 26(7) of the SEBI (SAST) Regulation, 2011 is

  • Sanofi Consumer Heal - Copy of Newspaper Publication

    11 Apr 2025, 3:35PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of Recommendations by the Committee of Independ

  • Sanofi Consumer Heal - Announcement under Regulation 30 (LODR)-Open Offer - Updates

    10 Apr 2025, 7:01PM Recommendations by the Committee of Independent Directors

  • Sanofi Consumer Heal - General Updates

    10 Apr 2025, 6:51PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Recommendations by the Committee of Independent Directors

  • Sanofi Consumer Heal - Intimation For Change In Record Date For Dividend

    9 Apr 2025, 6:35PM Intimation for change in Record Date for Dividend

  • Sanofi Consumer Heal - Revised Record date

    9 Apr 2025, 6:32PM Sanofi Consumer Healthcare India Limited had intimated the 28-Apr-2025 as the record date. The Company has now informed the Exchange that the Record d

  • Sanofi Consumer Heal - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    4 Apr 2025, 10:21PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ S

  • Sanofi Consumer Heal - Resignation

    4 Apr 2025, 6:11PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Resignation of Ms Maithilee Mistry as Chief Financial Officer of the Comp

  • Sanofi Consumer Heal - Announcement under Regulation 30 (LODR)-Change in Management

    4 Apr 2025, 6:02PM Resignation of Mr. Rupendra Sachdev as Senior Management Personnel of the Company

  • Sanofi Consumer Heal - Change in Management

    4 Apr 2025, 5:58PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Resignation of Mr. Rupendra Sachdev as Senior Management Personnel of the Com

  • Sanofi Consumer Heal - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

    4 Apr 2025, 5:56PM Resignation of Ms. Maithilee Mistry as the Whole-time Director and CFO of the Company.

  • Sanofi Consumer Heal - Announcement under Regulation 30 (LODR)-Resignation of Director

    4 Apr 2025, 5:48PM Resignation of Ms. Maithilee Mistry as the Whole-time Director and CFO of the Company.

  • Sanofi Consumer Heal - Resignation

    4 Apr 2025, 5:47PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Resignation of Ms Maithilee Mistry as Whole-time Director and CFO of the

  • Sanofi Consumer Heal - Shareholders meeting

    30 Mar 2025, 12:59AM Sanofi Consumer Healthcare India Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the

  • Sanofi Consumer Heal - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    30 Mar 2025, 12:38AM Voting Results for the Postal Ballot Notice dated 27th February 2025

  • Sanofi Consumer Heal - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    30 Mar 2025, 12:31AM Scrutinizer Report issued by M/s MMJB & Associates LLP w.r.t Postal Ballot Notice dated 27th february, 2025

  • Sanofi Consumer Heal - Trading Window-XBRL

    27 Mar 2025, 6:53PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Closure of Trading Window

  • Sanofi Consumer Heal - Trading Window

    27 Mar 2025, 6:52PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tradi

  • Sanofi Consumer Heal - Intimation Of Second (2Nd) Annual General Meeting Of The Company

    27 Mar 2025, 11:44AM Intimation of Second (2nd) Annual General Meeting of the Company

  • Sanofi Consumer Heal - General Updates

    27 Mar 2025, 11:42AM Sanofi Consumer Healthcare India Limited has informed the Exchange about the Second (2nd) Annual General Meeting of the Company

  • Sanofi Consumer Heal - Copy of Newspaper Publication

    25 Mar 2025, 5:07PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication related to notice of the Annual General Meeting

  • Sanofi Consumer Heal - Newspaper Publication - Annual General Meeting Through Video Conferencing Facility

    25 Mar 2025, 5:09PM Please find enclosed copies of newspaper publication related to notice of Annual General Meeting which will be held through VC facility on 5th May 202

  • Sanofi Consumer Heal - Reply to Clarification- Financial results

    12 Mar 2025, 5:52PM The Exchange had sought clarification from Sanofi Consumer Healthcare India Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of

  • Sanofi Consumer Heal - Determination Of Book Closure And Record Dates For Dividend

    5 Mar 2025, 6:25PM Further to our letter dated 20th February, 2025 wherein the Board recommended a final dividend of Rs. 55 per equity share, subject to the approval by

  • Sanofi Consumer Heal - Clarification - Financial Results

    5 Mar 2025, 5:54PM The Exchange has sought clarification from Sanofi Consumer Healthcare India Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of

  • Sanofi Consumer Heal - Record Date

    4 Mar 2025, 1:06PM Sanofi Consumer Healthcare India Limited has informed the Exchange that Record date for the purpose of Dividend is 28-Apr-2025.

  • Sanofi Consumer Heal - Determination Of Book Closure And Record Date For Dividend

    4 Mar 2025, 3:03PM Further to our letter dated 20th February, 2025, wherein the Board recommend a final dividend of Rs. 55 per equity share, subject to the approval by t

  • Sanofi Consumer Heal - Corporate Action-Board to consider Dividend

    4 Mar 2025, 1:07PM Sanofi Consumer Healthcare India Limited has informed the Exchange that the Record date for the purpose of Dividend is 28th April 2025

  • Sanofi Consumer Heal - Notice Of Shareholders Meetings-XBRL

    28 Feb 2025, 7:46PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot

  • Sanofi Consumer Heal - Copy of Newspaper Publication

    28 Feb 2025, 7:36PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication

  • Sanofi Consumer Heal - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    27 Feb 2025, 10:01PM Intimation of dispatch of Postal Ballot Notice to the Shareholders

  • Sanofi Consumer Heal - Shareholders meeting

    27 Feb 2025, 8:11PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Notice of Postal Ballot

  • Sanofi Consumer Heal - Copy of Newspaper Publication

    22 Feb 2025, 4:30PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication

  • Sanofi Consumer Heal - Outcome of Board Meeting-XBRL

    21 Feb 2025, 5:37PM SANOFI CONSUMER HEALTHCARE INDIA LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 20-Feb-2025 for Dividend

  • Sanofi Consumer Heal - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    21 Feb 2025, 3:57PM SANOFI CONSUMER HEALTHCARE INDIA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ S

  • Sanofi Consumer Heal - Agreements

    20 Feb 2025, 10:04PM Sanofi Consumer Healthcare India Limited has informed the Exchange about disclosure of details of agreements under Regulation 30A of SEBI (LODR) Regul

  • Sanofi Consumer Heal - Disclosure under Regulation 30A of LODR

    20 Feb 2025, 9:58PM Disclosure under Regulation 30A of LODR

  • Sanofi Consumer Heal - Integrated Filing- Financial

    20 Feb 2025, 8:50PM Integrated Filing Financials for the Quarter and Year ended December 31, 2024

  • Sanofi Consumer Heal - Integrated Filing (Financial)

    20 Feb 2025, 8:48PM Integrated Filing Financial for the quarter and Financial Year ended, 31st December, 2024

  • Sanofi Consumer Heal - Appointment

    20 Feb 2025, 8:42PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Appointment of M/s Kishore Bhatia and Associates as Cost Auditor of th

  • Sanofi Consumer Heal - Appointment

    20 Feb 2025, 8:40PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Appointment of M/S BNP Associates and Company as Secretarial Auditors o

  • Sanofi Consumer Heal - Considered And Approved Appointment Of M/S. BNP Associates & Co., Company Secretaries,\r\nAs The Secre

    20 Feb 2025, 8:34PM Considered and approved appointment of M/s BNP Associates and COmpany, Company Secretaries as Secretarial Auditor for 5 years

  • Sanofi Consumer Heal - Announcement under Regulation 30 (LODR)-Change in Management

    20 Feb 2025, 8:29PM Considered and approved re appointment of M/s Kishore Bhatia and Associates, Cost Accountants as Cost Auditorb for the COmpany

  • Sanofi Consumer Heal - Outcome of Board Meeting

    20 Feb 2025, 8:22PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Board meeting held on February 20, 2025.

  • Sanofi Consumer Heal - Corporate Action-Board approves Dividend

    20 Feb 2025, 8:19PM Approved final Dividend of Rs. 55 per equity share having the face value of Rs. 10 /- each for the Financial Year ended 31st December, 2024

  • Sanofi Consumer Heal - Approved The Audited Standalone Financial Statements Of The Company For The Quarter And Financial Year

    20 Feb 2025, 8:12PM Approved the Audited Standalone Financial Statement of the COmpany for the Quarter and Financial Year ended 31st December 2024

  • Sanofi Consumer Heal - Board Meeting Outcome for Approved The Audited Standalone Financial Statements Of The Company For The

    20 Feb 2025, 8:07PM We refer to our letter dated 14th February 2025, informing you of our Board Meeting that was scheduled\r\ntoday. In this regard, we wish to inform you

  • Sanofi Consumer Heal - Dividend

    20 Feb 2025, 8:00PM Sanofi Consumer Healthcare India Limited has informed the Exchange that Board of Directors at its meeting held on February 20, 2025, recommended Final

  • Sanofi Consumer Heal - Financial Result Updates

    20 Feb 2025, 7:59PM Sanofi Consumer Healthcare India Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.

  • Sanofi Consumer Heal - Trading Window-XBRL

    14 Feb 2025, 5:23PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Closure of Trading Window

  • Sanofi Consumer Heal - Board Meeting Intimation

    14 Feb 2025, 5:16PM Sanofi Consumer healthcare India Limited has informed the Exchange about Board Meeting to be held on 20-Feb-2025 to consider and approve the Yearly Au

  • Sanofi Consumer Heal - Board Meeting Intimation for Considering And Approval Of The Audited Financial Statements For The Fina

    14 Feb 2025, 5:09PM Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/02/2025 ,inter alia,
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Sanofi Consumer Healthcare India Ltd stock 

Name December-24 March-24 December-23
Assets 1.7 1.7 1.7
Liabilities 1.7 1.7 1.7
Equity 2 2 2
Gross Profit 0 0 -0.3
Net Profit 0 0 -0.3
Cash From Operating Activities -0.4 -0.4 -0.4
NPM(%) 0 0 0
Revenue 0 0 0
Expenses 0 0 0.3
ROE(%) 0 0 -0.13

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
17 Apr 2025 55 550 0 4756.85

Peers

Other companies within the same industry or sector that are comparable to Sanofi Consumer Healthcare India Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 559.00 -0.76 20.65 44569.83 35.34 0.54
Amines and Plasticizers Ltd 224.26 0.09 29.98 27180.43 361.94 0.22
Grauer and Weil (India) Ltd 115.60 0.00 32.66 111995.03 322.62 0.43
HP Adhesives Ltd 54.99 -1.58 25.82 45386.92 111.94 0.00

Company Info

The Company was incorporated as a public limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated May 10, 2023, issued by the Registrar of Companies, Central Registration Centre. Major Events and Milestones:2023 Incorporation of the Company 2024 Demerger, transfer and vesting of the Demerged Undertaking from Sanofi India Limited into the  Company on a going concern basis pursuant to the Scheme  2020 -Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030. 2021 -Sanofi completed acquisition of Kadmon. -Sanofi completed acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics. -Sanofi launched its new global employee share ownership plan. -Sanofi established three-year collaboration with Stanford Medicine to accelerate immunology research. 2022 -Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology. -Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine. -Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth. -Sanofi recognized by S&P as one of the most sustainability- committed companies. -Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board. 2023 -Sanofi's Consumer Healthcare Unit launches the Shared Care Collective, an advisory group working to advance sustainability. -Sanofi completes acquisition of Qunol. -Sanofi completes acquisition of Provention Bio, Inc. - Sanofi Consumer Healthcare launches new portal to unlock science and solve key challenges in self-care. 2024 -Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline.

The Company was incorporated as a public limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated May 10, 2023, issued by the Registrar of Companies, Central Registration Centre. Major Events and Milestones:2023 Incorporation of the Company 2024 Demerger, transfer and vesting of the Demerged Undertaking from Sanofi India Limited into the  Company on a going concern basis pursuant to the Scheme  2020 -Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030. 2021 -Sanofi completed acquisition of Kadmon. -Sanofi completed acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics. -Sanofi launched its new global employee share ownership plan. -Sanofi established three-year collaboration with Stanford Medicine to accelerate immunology research. 2022 -Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology. -Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine. -Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth. -Sanofi recognized by S&P as one of the most sustainability- committed companies. -Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board. 2023 -Sanofi's Consumer Healthcare Unit launches the Shared Care Collective, an advisory group working to advance sustainability. -Sanofi completes acquisition of Qunol. -Sanofi completes acquisition of Provention Bio, Inc. - Sanofi Consumer Healthcare launches new portal to unlock science and solve key challenges in self-care. 2024 -Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline.

Read More

Parent Organisation

Sanofi Consumer Healthcare India Ltd.

Founded

10/05/2023

Managing Director

NSE Symbol

SANOFICONREQ

FAQ

The current price of Sanofi Consumer Healthcare India Ltd is ₹ 4943.00.

The 52-week high for Sanofi Consumer Healthcare India Ltd is ₹ 4955.10 and the 52-week low is ₹ 4937.70.

The market capitalization of Sanofi Consumer Healthcare India Ltd is currently ₹ 11384.04. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sanofi Consumer Healthcare India Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sanofi Consumer Healthcare India Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sanofi Consumer Healthcare India Ltd shares.

The CEO of Sanofi Consumer Healthcare India Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT